Immunogenic RNA in the immunotherapy of cancer: the transfer of antitumor cytotoxic activity and tuberculin sensitivity to human lymphocytes using xenogeneic ribonucleic acid.
D000818:Animals; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D002623:Chemistry Techniques, Analytical; D002850:Chromatography, Gel; D003601:Cytotoxicity Tests, Immunologic; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007106:Immune Sera; D007167:Immunotherapy; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D012313:RNA / Q000302:isolation & purification / Q000627:therapeutic use*; D012756:Sheep / Q000276:immunology; D013045:Species Specificity; D014374:Tuberculin Test
D007106:Immune Sera; D012313:RNA